Institution
Imperial Chemical Industries
About: Imperial Chemical Industries is a based out in . It is known for research contribution in the topics: Alkyl & Catalysis. The organization has 8189 authors who have published 7809 publications receiving 190252 citations. The organization is also known as: Imperial Chemical Industries Ltd.
Topics: Alkyl, Catalysis, Alkoxy group, Polymer, Coating
Papers published on a yearly basis
Papers
More filters
TL;DR: The difference in metabolism of PER to TCA in mice and rats leads to thespecies difference in hepatic peroxisome proliferation which is believed to be the basis of the species difference in hepatocarcinogenicity.
65 citations
TL;DR: In this article, a review from the viewpoint of the formulator of industrial catalysts with the objective of explaining the practice but giving only such general theories and speculations as the author has found to be of real utility.
65 citations
Patent•
11 Jun 1981TL;DR: In this paper, a new zeolite material designated EU-1 having a molar composition expressed by the formula: 0.5 to 1.5 R.sub.2 O.
Abstract: A new zeolite material designated EU-1 having a molar composition expressed by the formula: 0.5 to 1.5 R.sub.2 O:Y.sub.2 O.sub.3 : at least 10 XO.sub.2 :0 to 100 H 2 O wherein R is a monovalent cation or 1 /n of a cation of valency n, X is silicon and/or germanium, Y is one or more of aluminum, iron, gallium or boron, and H 2 O is water of hydration additional to water notionally present when R is H, and having an X-ray pattern substantially as set out in Tables 1 and 2 is prepared from a reaction mixture containing XO 2 (preferably silica), Y 2 O 3 (preferably alumina) and a dicationic alkylated polymethylene diamine. The new zeolite is useful in catalytic processes, especially xylenes isomerization.
65 citations
TL;DR: Cerebrospinal fluid concentrations of beta-receptor blockers were poor predictors of brain concentrations and central nervous system-related side effects associated mainly with lipophilic beta- receptor blockers possibly result from high brain tissue concentrations.
Abstract: 1. Sixteen neurosurgical patients received (oral) beta-adrenoreceptor-blocking agents (beta-receptor blockers) for 3-22 days. 2. Lipophilic beta-receptor blockers (propranolol) and metoprolol appeared in cerebrospinal fluid at concentrations similar to the free drug plasma concentration. 3. Cerebrospinal fluid concentrations of beta-receptor blockers were poor predictors of brain concentrations. 4. Both lipophilic beta-receptor blockers appeared in high concentrations in the brain: the brain/plasma ratio was approximately 15:1. 5. Hydrophilic atenolol appeared at low concentrations in brain tissue (about 20 times lower than the lipophilic beta-receptor blockers): the brain/plasma ratio was approximately 0.1:1. 6. Central nervous system-related side effects associated mainly with lipophilic beta-receptor blockers possibly result from high brain tissue concentrations.
65 citations
TL;DR: Results indicate that hydrolysis of ATP to adenosine or 5' AMP is not a pre-requisite for activation of the P1-receptor in the guinea-pig atrium.
65 citations
Authors
Showing all 8189 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Richard A. Dixon | 126 | 603 | 71424 |
| Donald Mackay | 103 | 468 | 35105 |
| Graham J. Hutchings | 97 | 995 | 44270 |
| George E. P. Box | 94 | 276 | 131808 |
| Ian Kimber | 91 | 620 | 28629 |
| Ian D. Wilson | 80 | 594 | 33379 |
| Paul D. Beer | 76 | 544 | 27398 |
| Philip J. White | 75 | 314 | 26523 |
| Vernon C. Gibson | 71 | 340 | 22163 |
| A. Keller | 62 | 304 | 14920 |
| Michael Bowker | 62 | 304 | 12119 |
| Brian Vincent | 59 | 228 | 13366 |
| Brian P. Griffin | 56 | 373 | 14337 |
| Manfred Bochmann | 56 | 331 | 12573 |
| Diana Anderson | 54 | 323 | 16177 |